Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers

Bak E, et al. Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes. Int J Obes. 2010;34(2):250–60.

CAS  Article  Google Scholar 

Barrero MJ, Boué S, Belmonte JCI. Epigenetic mechanisms that regulate cell identity. Cell Stem Cell. 2010;7(5):565–70.

CAS  PubMed  Article  Google Scholar 

Bhatia K, Das A. Combinatorial drug therapy in cancer-new insights. Life Sciences. 2020;118134.

Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21(9):3233.

CAS  PubMed Central  Article  Google Scholar 

Burotto M, et al. The MAPK pathway across different malignancies: a new perspective. Cancer. 2014;120(22):3446–56.

CAS  PubMed  Article  Google Scholar 

Cai Q, et al. Toxicity of Evodiae fructus on rat liver mitochondria: the role of oxidative stress and mitochondrial permeability transition. Molecules. 2014;19(12):21168–82.

PubMed  PubMed Central  Article  Google Scholar 

Chan AL-F, et al. Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. Molecules. 2009;14(4):1342–52.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chandarlapaty S. Negative feedback and adaptive resistance to the targeted therapy of cancer. Cancer Discov. 2012;2(4):311–9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chang W-L, et al. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and-9 in human hormone-refractory prostate cancer cells–a critical role of cdk1 in mitotic entry. Biochem Pharmacol. 2015;94(1):12–21.

CAS  PubMed  Article  Google Scholar 

Chen MC, et al. Anti-proliferative effects of evodiamine on human thyroid cancer cell line ARO. J Cell Biochem. 2010;110(6):1495–503.

CAS  PubMed  Article  Google Scholar 

Chen T-C, et al. Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells. Phytomedicine. 2016;23(1):68–78.

CAS  PubMed  Article  Google Scholar 

Cheng ZM, et al. Effects of evodiamine on invasion and polo-like kinase 1 expression of human gastric cancer cell [J]. J Jiangsu Univ (Medicine Edition) 2011;21:69–72.

Chien C-C, et al. Activation of JNK contributes to evodiamine-induced apoptosis and G 2/M arrest in human colorectal carcinoma cells: a structure-activity study of evodiamine. PLoS One. 2014;9(6):e99729.

PubMed  PubMed Central  Article  Google Scholar 

Chou S-T, et al. Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice. BMC Complement Altern Med. 2017;17(1):121.

PubMed  PubMed Central  Article  Google Scholar 

Cohen SM, et al. Hepatotoxicity associated with the use of White Flood, a nutritional supplement. Pract Gastroenterol. 2012;36(10):45–7.

Google Scholar 

Dong G, et al. Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents. J Med Chem. 2010;53(21):7521–31.

CAS  PubMed  Article  Google Scholar 

Dong G, et al. New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure–activity relationship analysis and biological evaluations. 2012;55(17):7593–613.

Du J, et al. Evodiamine induces apoptosis and inhibits metastasis in MDA-MB-231 human breast cancer cells in vitro and in vivo. Oncol Rep. 2013;30(2):685–94.

CAS  PubMed  Article  Google Scholar 

Du J, et al. Berberine and evodiamine act synergistically against human breast cancer MCF-7 cells by inducing cell cycle arrest and apoptosis. Anticancer Res. 2017;37(11):6141–51.

CAS  PubMed  Google Scholar 

Duchartre Y, Kim Y-M, Kahn M. The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol. 2016;99:141–9.

PubMed  Article  Google Scholar 

Ebi H. EGFR-Mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition. Ann Oncol. 2012;23:xi41.

Article  Google Scholar 

Fang C, et al. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells. PLoS One. 2014;9(12):e115204.

PubMed  PubMed Central  Article  Google Scholar 

Fang Q, et al. Evodiamine selectively inhibits multiple myeloma cell growth by triggering activation of intrinsic apoptosis pathway. Onco Targets Ther. 2019;12:11383.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Fendler A, et al. Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients. Nat Commun. 2020;11(1):1–16.

Article  Google Scholar 

García-Gómez R, Bustelo XR, Crespo P. Protein–protein interactions: emerging oncotargets in the RAS-ERK pathway. Trends Cancer. 2018;4(9):616–33.

PubMed  Article  Google Scholar 

Gu Y, Mohammad IS, Liu Z. Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors. Oncol Lett. 2020;19(4):2585–94.

CAS  PubMed  PubMed Central  Google Scholar 

Guan X, et al. Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro. Eur J Pharmacol 2020;173031.

Guo X-X, et al. Evodiamine induces apoptosis in SMMC-7721 and HepG2 cells by suppressing NOD1 signal pathway. Int J Mol Sci. 2018;19(11):3419.

PubMed Central  Article  Google Scholar 

Guo Q, et al. Evodiamine inactivates NF-κB and potentiates the antitumor effects of gemcitabine on tongue cancer both in vitro and in vivo. Onco Targets Ther. 2019;12:257.

CAS  PubMed  Article  Google Scholar 

Guo YJ, et al. ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997–2007.

PubMed  PubMed Central  Google Scholar 

Gupta SC, et al. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta (BBA)-Gene Regul Mech. 2010;1799(10–12):775–87.

CAS  Article  Google Scholar 

Han S, et al. Evodiamine selectively targets cancer stem-like cells through the p53–p21-Rb pathway. Biochem Biophys Res Commun. 2016;469(4):1153–8.

CAS  PubMed  Article  Google Scholar 

He C, Wan H. Drug metabolism and metabolite safety assessment in drug discovery and development. Expert Opin Drug Metab Toxicol. 2018;14(10):1071–85.

CAS  PubMed  Article  Google Scholar 

Heo SK, et al. Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation. J Cell Biochem. 2009;107(1):123–33.

CAS  PubMed  Article  Google Scholar 

Hong Z, et al. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells. Int J Oncol. 2020;56(3):783–93.

CAS  PubMed  PubMed Central  Google Scholar 

Hu J, et al. Improved absorption and in vivo kinetic characteristics of nanoemulsions containing evodiamine–phospholipid nanocomplex. Int J Nanomed. 2014;9:4411.

Google Scholar 

Hu C, et al. Evodiamine sensitizes BGC-823 gastric cancer cells to radiotherapy in vitro and in vivo. Mol Med Rep. 2016;14(1):413–9.

CAS  PubMed  Article  Google Scholar 

Hu C-Y, et al. Evodiamine exerts an anti-hepatocellular carcinoma activity through a WWOX-dependent pathway. Molecules. 2017;22(7):1175.

PubMed Central  Article  Google Scholar 

Hu X, et al. Antiproliferative effects of alkaloid evodiamine and its derivatives. Int J Mol Sci. 2018;19(11):3403.

PubMed Central  Article  Google Scholar 

Huang Y-C, Guh J-H, Teng C-M. Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytes. Life Sci. 2004;75(1):35–49.

CAS  PubMed  Article  Google Scholar 

Huang J, et al. Antiproliferation effect of evodiamine in human colon cancer cells is associated with IGF-1/HIF-1α downregulation. Oncol Rep. 2015;34(6):3203–11.

CAS  PubMed  Article  Google Scholar 

Huang C, et al. Effect of evodiamine and berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-β1. Oncol Rep. 2017;37(3):1637–45.

CAS  PubMed  Article  Google Scholar 

Hung P-H, et al. Inhibitory effect of evodiamine on aldosterone release by Zona glomerulosa cells in male rats. Chin J Physiol. 2001;44(2):53–8.

CAS  PubMed  Google Scholar 

Hwang ST, et al. Evodiamine mitigates cellular growth and promotes apoptosis by targeting the c-met pathway in prostate cancer cells. Molecules. 2020;25(6):1320.

CAS  PubMed Central  Article  Google Scholar 

Hyun SY, et al. Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70. Theranostics. 2021;11(6):2932.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jia J, et al. Inhibition of human liver cancer cell growth by evodiamine involves apoptosis and deactivation of PI3K/AKT pathway. Appl Biol Chem. 2020;63(1):1–8.

Article 

留言 (0)

沒有登入
gif